Vident Investment Advisory, LLC Rubius Therapeutics, Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.79 - $5.98 $71,872 - $544,048
-90,978 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$4.25 - $10.4 $64,451 - $157,716
15,165 Added 20.0%
90,978 $501,000
Q4 2021

Feb 14, 2022
BUY
$9.68 - $17.74 $198,236 - $363,297
20,479 Added 37.01%
75,813 $734,000
Q3 2021

Nov 12, 2021
SELL
$17.6 - $25.91 $69,555 - $102,396
-3,952 Reduced 6.67%
55,334 $989,000
Q2 2021

Aug 13, 2021
BUY
$22.26 - $28.43 $1.32 Million - $1.69 Million
59,286 New
59,286 $1.45 Million

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email